FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387063522> ?p ?o ?g. }

• W4387063522 endingPage "109920" @default.
• W4387063522 startingPage "109920" @default.
• W4387063522 abstract "Emerging data suggest immune checkpoint inhibitors (ICI) and stereotactic radiosurgery (SRS) or radiotherapy (SRT) may work synergistically, potentially increasing both efficacy and toxicity. This manuscript characterizes factors associated with intracranial control and radiation necrosis in this group.All patients had non-small cell lung cancer, renal cell carcinoma, or melanoma and were treated from 2013 to 2021 at two institutions with ICI and SRS/SRT. Univariate and multivariate analysis were used to analyze factors associated with local failure (LF) and grade 2+ (G2 + ) radiation necrosis.There were 179 patients with 549 metastases. The median follow up from SRS/SRT was 14.7 months and the median tumor size was 7 mm (46 tumors ≥ 20 mm). Rates of LF and G2 + radiation necrosis per metastasis were 5.8% (32/549) and 6.9% (38/549), respectively. LF rates for ICI +/- 1 month from time of radiation versus not were 3% (8/264) and 8% (24/285) (p = 0.01), respectively. G2 + radiation necrosis rates for PD-L1 ≥ 50% versus < 50% were 17% (11/65) and 3% (5/203) (p=<0.001), respectively. PD-L1 ≥ 50% remained significantly associated with G2 + radiation necrosis on multivariate analysis (p = 0.03). Rates of intracranial failure were 54% (80/147) and 17% (4/23) (p = 0.001) for those without and with G2 + radiation necrosis, respectively.PD-L1 expression (≥50%) may be associated with higher rates of G2 + radiation necrosis, and there may be improved intracranial control following the development of radiation necrosis. Administration of ICIs with SRS/SRT is overall safe, and there may be some local control benefit to delivering these concurrently." @default.
• W4387063522 created "2023-09-27" @default.
• W4387063522 creator A5001015275 @default.
• W4387063522 creator A5003643920 @default.
• W4387063522 creator A5003718738 @default.
• W4387063522 creator A5004027712 @default.
• W4387063522 creator A5005502092 @default.
• W4387063522 creator A5024010972 @default.
• W4387063522 creator A5026005369 @default.
• W4387063522 creator A5028848898 @default.
• W4387063522 creator A5034501270 @default.
• W4387063522 creator A5040202861 @default.
• W4387063522 creator A5046203056 @default.
• W4387063522 creator A5047468145 @default.
• W4387063522 creator A5052948620 @default.
• W4387063522 creator A5061533554 @default.
• W4387063522 creator A5061866268 @default.
• W4387063522 creator A5063075621 @default.
• W4387063522 creator A5063679763 @default.
• W4387063522 creator A5072801311 @default.
• W4387063522 creator A5079452824 @default.
• W4387063522 creator A5090193008 @default.
• W4387063522 date "2023-12-01" @default.
• W4387063522 modified "2023-10-14" @default.
• W4387063522 title "Factors Associated with Radiation Necrosis and Intracranial Control in Patients Treated with Immune Checkpoint Inhibitors and Stereotactic Radiotherapy" @default.
• W4387063522 cites W1534922464 @default.
• W4387063522 cites W1982488143 @default.
• W4387063522 cites W2078730920 @default.
• W4387063522 cites W2083128109 @default.
• W4387063522 cites W2103220202 @default.
• W4387063522 cites W2145376545 @default.
• W4387063522 cites W2159314579 @default.
• W4387063522 cites W2169943019 @default.
• W4387063522 cites W2527905628 @default.
• W4387063522 cites W2771966188 @default.
• W4387063522 cites W2782652081 @default.
• W4387063522 cites W2888298425 @default.
• W4387063522 cites W2888599070 @default.
• W4387063522 cites W2890381929 @default.
• W4387063522 cites W2893824814 @default.
• W4387063522 cites W2899172402 @default.
• W4387063522 cites W2918511688 @default.
• W4387063522 cites W2919428266 @default.
• W4387063522 cites W2923367618 @default.
• W4387063522 cites W2938759947 @default.
• W4387063522 cites W2966453812 @default.
• W4387063522 cites W2999281781 @default.
• W4387063522 cites W3014209163 @default.
• W4387063522 cites W3014802141 @default.
• W4387063522 cites W3015154527 @default.
• W4387063522 cites W3040100953 @default.
• W4387063522 cites W3044423036 @default.
• W4387063522 cites W3086541801 @default.
• W4387063522 cites W3088712443 @default.
• W4387063522 cites W3093931238 @default.
• W4387063522 cites W3122287483 @default.
• W4387063522 cites W3183933090 @default.
• W4387063522 cites W4205648207 @default.
• W4387063522 cites W4206898533 @default.
• W4387063522 cites W4207010522 @default.
• W4387063522 cites W4211260961 @default.
• W4387063522 cites W4214765060 @default.
• W4387063522 cites W4228997058 @default.
• W4387063522 cites W4281618890 @default.
• W4387063522 cites W4296067450 @default.
• W4387063522 cites W634312238 @default.
• W4387063522 doi "https://doi.org/10.1016/j.radonc.2023.109920" @default.
• W4387063522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37769968" @default.
• W4387063522 hasPublicationYear "2023" @default.
• W4387063522 type Work @default.
• W4387063522 citedByCount "0" @default.
• W4387063522 crossrefType "journal-article" @default.
• W4387063522 hasAuthorship W4387063522A5001015275 @default.
• W4387063522 hasAuthorship W4387063522A5003643920 @default.
• W4387063522 hasAuthorship W4387063522A5003718738 @default.
• W4387063522 hasAuthorship W4387063522A5004027712 @default.
• W4387063522 hasAuthorship W4387063522A5005502092 @default.
• W4387063522 hasAuthorship W4387063522A5024010972 @default.
• W4387063522 hasAuthorship W4387063522A5026005369 @default.
• W4387063522 hasAuthorship W4387063522A5028848898 @default.
• W4387063522 hasAuthorship W4387063522A5034501270 @default.
• W4387063522 hasAuthorship W4387063522A5040202861 @default.
• W4387063522 hasAuthorship W4387063522A5046203056 @default.
• W4387063522 hasAuthorship W4387063522A5047468145 @default.
• W4387063522 hasAuthorship W4387063522A5052948620 @default.
• W4387063522 hasAuthorship W4387063522A5061533554 @default.
• W4387063522 hasAuthorship W4387063522A5061866268 @default.
• W4387063522 hasAuthorship W4387063522A5063075621 @default.
• W4387063522 hasAuthorship W4387063522A5063679763 @default.
• W4387063522 hasAuthorship W4387063522A5072801311 @default.
• W4387063522 hasAuthorship W4387063522A5079452824 @default.
• W4387063522 hasAuthorship W4387063522A5090193008 @default.
• W4387063522 hasConcept C121608353 @default.
• W4387063522 hasConcept C126322002 @default.
• W4387063522 hasConcept C126894567 @default.
• W4387063522 hasConcept C143998085 @default.
• W4387063522 hasConcept C144301174 @default.
• W4387063522 hasConcept C2778164965 @default.

• next